Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE), a healthcare technology company that has developed an exclusive AI software to think like a doctor, is pleased to announce that it has closed a non-brokered private placement offering, as previously announced on May 12, 2021, for total gross proceeds of $5,004,000 (the “Private Placement”).
The Company has allotted and issued 1,000,800 common shares (the “Shares”) at a price of $5.00 per Share.
In relation to the Private Placement, the Company has paid finder’s fees of $185,140 and issued 36,880 finder’s warrants (the “Finders Warrants”) to arm’s-length parties. Each Finders Warrant is exercisable into one common share at a price of $5.00 per share, for a period of 18 months.
The Company will use the proceeds from the Private Placement towards the Company’s upcoming product launches, annual marketing plan and general working capital. All securities issued pursuant to the Private Placement will be subject to a hold period expiring October 18, 2021.